DaVita Inc. (DVA)

In Q4 2024, DaVita reported revenue growth of 4.7%, beat EPS estimates by 4.3%, and repurchased 2.3 million shares for $367 million. In Q1 2025, DaVita beat profit estimates, but results were impacted by a severe flu season and winter storms, which reduced U.S. treatment volumes. A ransomware attack in April 2025 led to data encryption and leakage, resulting in lawsuits and increased IT expenses. In Q2 2025, DaVita beat profit estimates due to steady demand and seasonal factors, with revenue up 6.1%. As of September 25, 2025, the share price was $130.27, a decline of 19.72% from September 26, 2024. Analyst ratings in September 2025 included an upgrade to "buy" from Wall Street Zen and a reduced price objective from Barclays.

DaVita experiences demand seasonality, with second-quarter profits positively impacted by more patients meeting their co-insurance and deductibles. Conversely, severe flu seasons and winter storms can reduce U.S. treatment volumes, leading to elevated patient mortality rates and missed treatments, as observed in Q1 2025.

DaVita Inc. is a leading healthcare provider focused on kidney care and dialysis services for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The company's core business is dialysis services, offering both in-center and home dialysis options, including outpatient, inpatient, and home-based dialysis with training and support. DaVita also provides Integrated Kidney Care (IKC) for holistic patient care and ancillary services like laboratory testing, pharmacy services (DaVita Rx), clinical research programs, and infusion therapy services through HomeChoice Partners.

As of December 31, 2024, DaVita operated 3,166 outpatient dialysis centers worldwide, with 2,657 in the United States and 509 in 13 other countries. DaVita has expanded internationally, particularly in Latin America with operations in Brazil, Colombia, Chile, and Ecuador, and also has a presence in Germany and China.

DaVita's brand reputation has been influenced by both positive and negative events. Positively, DaVita published its Community Care report in May 2025, highlighting its ESG commitments and was recognized as an employer of choice by Fortune, USA Today, and Newsweek. Negatively, a ransomware attack in April 2025 led to data encryption and leakage, triggering lawsuits and regulatory scrutiny. Additionally, a $34.49 million settlement in 2024 for alleged kickbacks and a history of lawsuits have negatively impacted its reputation.

As of June 30, 2025, institutional ownership of DaVita Inc. was 98.56% of total shares outstanding. Major institutional owners include Berkshire Hathaway Inc., Vanguard Group Inc., BlackRock, Inc., State Street Corp., Invesco Ltd., Morgan Stanley, Geode Capital Management, Llc, and Gates Capital Management, Inc.